MONDAY, Feb. 26, 2024 (HealthDay News) — Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial. An injected experimental drug called rusfertide appears effective in reducing the excess production of redContinue Reading

THURSDAY, Feb. 22, 2024 (HealthDay News) — A deficiency or absence of viable sperm in a man’s semen could spell danger for him and those closely related to him, new research suggests. Cancers are more likely to occur in these men and their families, reports a team led by Dr.Continue Reading

MONDAY, Feb. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer. Amtagvi, made by Iovance Biotherapeutics Inc., becomes the first cellular therapy approved to treat this form of solid tumor cancer. “Unresectable, orContinue Reading